FDANonrulemakingFDA-2010-N-0449
Who commented on this docket
Risks and Benefits of Lon-Term Use of Nicotine Replacement Therapy Produts; Public Workshowp; Request for Comments
1 organizations filed 1 public comment on Risks and Benefits of Lon-Term Use of Nicotine Replacement Therapy Produts; Public Workshowp; Request for Comments, at the Food and Drug Administration. The comment window closed 5692d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 5692d ago
Commenters (1)
- American Academy of Pediatrics (AAP)1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.